The 2010 Journal Symposium will highlight up-andcoming and noteworthy concepts in anesthesia research and clinical practice. Anesthesiologists have generally considered their work done and successful if patients were well a day or two after surgery. However, there is increasing evidence that perioperative management has the potential to influence patient outcomes weeks, months, and perhaps even years after surgery. This symposium will explore aspects of anesthetic care most likely to be associated with alterations in long-term outcome.
Three invited speakers will lead the session. Daniel I. Sessler, M.D., Professor and Chair, Department of OUTCOMES RE-SEARCH, The Cleveland Clinic, will discuss long-term consequences of intraoperative management; Philip J. Devereaux, M.D., Ph.D., Associate Professor, McMaster University Departments of Medicine (Division of Cardiology) and Clinical Epidemiology and Biostatistics, will describe how we can substantially cut the risk of major vascular complications among patients undergoing noncardiac surgery in the coming decade; and Simon C. Body, M.B., Ch.B., M.P.H., Assistant Professor of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, will discuss the team role of intraoperative transfusion management upon long-term outcomes.
These lectures will be followed by 10 abstracts presented orally and selected for their relevance to the Symposium topic. The text for each abstract can be found at the American Society of Anesthesiology (ASA) abstract Web site or in the CD-ROM that is included in this issue of the Journal. "Can Regional Anesthesia for Lymph Node Dissection Improve Prognosis in Malignant Melanoma?" by Gerhard Brodner, Hugo Van Aken, Björn Ellger, and Hans-Joachim Schulze, Anaesthesie, Fachklinik Hornheide, Muenster, Germany and Anaesthesie, Universitaetsklinik, Muenster, Germany. In a retrospective analysis, 52 patients having melanoma surgery and lymph node dissection under spinal anesthesia were compared with 221 who had general anesthesia with sevoflurane and sufentanil (n ϭ 118) or total intravenous anesthesia with propofol and remifentanil (n ϭ 103). There was a trend (P ϭ 0.087) toward significantly better cumulative survival over 10 yr after spinal anesthesia as compared with general anesthesia: mean survival time for spinal anesthesia was 96 months (95% CI: 81-110 months) compared with 70 months for general anesthesia (54 -87 months) . These data support the hypothesis that regional anesthesia might improve the long-run prognosis of malignant melanoma patients. The authors are conducting a randomized trial to confirm this hypothesis. [A1183] "Preoperative Dexamethasone Enhances Quality of Life Measures after Hospital Discharge" by Glenn S. Murphy, Joseph W. Szokol, Michael J. Avram, Steven B. dent: *3/*3: 0%; *3/*3(*2): 3%, *2/*2(*1): 8%, *1/*1: 21% (P ϭ 0.002). Thus, functional GNAS htSNPs result in haplotype-dependent differences in G-s expression, which are associated with altered mortality after CABG. [A1186] "Postoperative B-type Natriuretic Peptide Associates with Longer-term Physical Function after CABG" by Amanda A. Fox, Edward R. Marcantonio, Charles D. Collard, Stanton K. Shernan, and Simon C. Body, Brigham & Women's Hospital, Boston, Massachusetts, Beth Israel Deaconess Medical Center, Boston, Massachusetts, and Division of Cardiovascular Anesthesia, Texas Heart Institute, Houston, Texas. The authors tested the hypothesis that peak postoperative B-type natriuretic peptide (BNP) is associated with physical function assessed 1 and 2 yr after CABG surgery after adjusting for clinical risk factors, including preoperative physical function. A total of 755 patients had postoperative SF-36 physical function data. After multivariable adjustment, peak postoperative BNP remained independently associated with 1 and 2 yr physical function score (effect estimate for log 10 increase ϭ Ϫ2.76; P ϭ 0.03). Whether medical management to reduce postoperative BNP concentrations after CABG surgery will improve longterm physical function remains to be determined. [A1187] "Perioperative Management of Antiplatelet Agents: Randomized, Double-blind, Placebo-controlled Trial" by Jean Mantz and For the STRATAGEM Study Group. Anesthesia and Intensive Care, Beaujon University Hospital, Clichy, France and Cardiology, Bichat Claude Bernard, Paris, France. This multicenter, randomized study compared the impact of maintenance versus discontinuation of aspirin throughout the perioperative period on bleeding and thrombotic outcomes in high-risk patients undergoing elective, noncoronary surgery. Antiplatelet therapy was substituted for aspirin (75 mg) or placebo 10 days before surgery. The primary endpoint was a score involving both major thrombotic and bleeding adverse events occurring within the first 30 postoperative days. No significant difference was observed in primary outcome scores between groups, including mortality. These data suggest that the rate of major thrombotic and bleeding complications in high-risk patients undergoing elective, noncoronary surgery does not differ significantly when aspirin is maintained throughout the perioperative period compared to patients in whom preoperative antiplatelet therapy is discontinued. [A1188] "Smoking and Perioperative Outcomes" by Alparslan Turan, Jing You, Andrea Kurz, Leif Saager, and Daniel I. Sessler, Department of OUTCOMES RESEARCH, The Cleveland Clinic, Cleveland, Ohio. Telephone "quitlines" for smoking cessation have been shown to be of proven efficacy in helping callers quit smoking and are currently available in all states at minimal cost. This pilot trial determined the efficacy of brief intervention on the utilization of telephone quitlines for smoking cessation. Patients (n ϭ 300) scheduled for elective noncardiac surgery were randomized to either receive a 3 min intervention focused on encouraging quitline use or a brief stop-smoking intervention of similar duration that did not specifically encourage quitline utilization. Compared with the control group, the quitline intervention increased quitline utilization from 3% to 15% (P Ͻ 0.001). Although this study was not powered to evaluate abstinence outcomes, the continuous abstinence rate at 30 days after surgery was 25% in the quitline group, in contrast to 19% in the control group (P ϭ NS). These data demonstrate that a brief provider intervention for smoking cessation significantly increased telephone quitline utilization. Using a genome-wide association scan, this study sought to determine genetic risk factors for postoperative cognitive dysfunction (POCD) in patients of European descent undergoing coronary artery bypass grafting with cardiopulmonary bypass. Postoperative cognitive decline was defined using factor analysis as a change between cognitive scores assessed at baseline and 6 weeks postoperatively. A total of 602 subjects had complete genotype and cognitive phenotypes. Four sequence variants on chromosome 6q16.1 were found to be strongly associated with POCD, even after adjusting for traditional risk factors associated with POCD (age, baseline cognition, years of education, and diabetes). All of the identified variants are near a gene known to have a critical role in cognitive performance (Ephrin A7 receptor, EPHA7). These data suggest that atrisk populations can be identified preoperatively and targeted with strategies to reduce POCD. [A1192] "Deep Hypothermia during Aortic Arch Surgery with Circulatory Arrest Predicts Early Mortality" by Wei Pan, January Tsai, Scott A. LeMaire, and Joseph S. Coselli, Baylor College of Medicine, and Michael E. DeBakey, Department of Surgery, Baylor College of Medicine, Houston, Texas. This study compared perioperative outcomes in patients who underwent moderate (nasopharyngeal temperature 20°C; n ϭ 79) versus deep (less than 20°C; n ϭ 149) hypothermia during aortic arch repair with circulatory arrest and selective antegrade cerebral perfusion. Linear regression was used to determine whether deep hypothermia was independently associated with adverse postoperative outcomes. Compared with moderate hypothermia, deep hypothermia was independently associated with greater risk of in-hospital death (7.6% vs. 0.7%; OR 8.9; 95% CI 1.2-78.9; P ϭ 0.048), early mortality (8.9% vs. 2.1%; OR 4.6; 95% CI 1.2-18.2; P ϭ 0.031), hospital stay more than 10 days (59% vs. 44%; OR 1.9; 95% CI 1.1-3.5; P ϭ 0.026), and longer CPB time (156 vs. 140 min; P ϭ 0.004). These data suggest that deep hypothermia is an independent predictor of perioperative mortality and hospital stay. [A1191]
"Does Preoperative Aspirin Reduce Cardiocerebral Ischemic Events in Cardiac Surgery Patients?" by Longhui Cao, Nishanthi Kandiah, Scott Silvestry, Zvi Grunwald, and Jian-Zhong Sun, Thomas Jefferson University and Cardiothoracic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania. This retrospective study investigated whether preoperative aspirin therapy reduces cardiocerebral ischemic events in patients undergoing cardiac surgery. Patients were divided into two groups: those taking (n ϭ 860) or not taking (n ϭ 288) aspirin within 5 days preceding surgery. Multivariate logistic regression revealed that preoperative aspirin use was independently associated with a reduced incidence of postoperative cardiocerebral ischemic events (8.6% vs. 12.9%; OR ϭ 0.638; 95% CI 0.418 -0.976; P ϭ 0.037). Thirty-day mortality did not significantly differ between groups (4.2% vs. 5.8%; OR ϭ 0.708; 95% CI 0.386 -1.301; P ϭ 0.264). These data suggest that preoperative aspirin use is associated with reduced major cardiocerebral ischemic events in patients undergoing cardiac surgery. This is the third annual session of abstracts sponsored by ANESTHESIOLOGY and selected by Drs. Hugh C. Hemmings, Judy R. Kersten, and James C. Eisenach. The abstracts were selected based on broad interest and scientific importance and were selected from the top-rated abstracts as scored by each scientific subcommittee that evaluated abstracts for presentation at the Annual Meeting. This session highlights 12 outstanding abstracts, which will be presented in traditional oral format followed by a brief discussion. Exercise is often prescribed for chronic pain, and regular exercise reduces behavioral measures of chronic pain in animals. In rats with surgically-induced chronic neuropathic pain, regular exercise reduced measures of pain. This analgesic effect of exercise was prevented or acutely reversed by opioid receptor antagonists administered systemically or intracerebroventricullary, but not spinally, suggesting that moderate exercise engages opioid receptors in the brain to relieve neuropathic pain. [A777] "Genetic Contribution to the Pain and Progress of Labor" by Elena Reitman, Pamela Flood, Steven Shafer, and Richard Smiley, Columbia University, New York, New York. Progress of labor and time course of pain during labor vary considerably among individuals, possibly reflecting, in part, genetic differences. Using a recently developed mathematical approach to model labor progress and pain during labor, 150 women were genotyped for the ␤ 2 -adrenoceptor and -opioid receptor genes and prospectively studied during labor. The ␤ 2adrenoceptor genotype at position 27 was associated with later transition to active labor and the homozygous (GG) genotype at position 118 of the opioid receptor was associated with more rapid development of pain during labor. Hydrogen sulfide (HS) is a gas produced by the enzyme cystathionine lyase (CSE) that may play a deleterious role during sepsis by promoting vasodilation, increasing endothelial permeability, and decreasing survival. Using a genetic deletion model, survival, mesenteric artery responses to phenylephrine, and endothelial barrier function were tested in wild type or CSE Ϫ/Ϫ mice during sepsis after either cecal puncture or treatment with LPS. Survival was increased, vasodilatory responses were decreased, and endothelial permeability was attenuated in mice lacking CSE during sepsis. The results suggest that HS generated by CSE may represent a novel therapeutic target for inhibition during sepsis. [A779] "Chronic Perioperative ␤-Blockade Is Superior to Acute Postoperative ␤-Blockade" by Christoph Ellenberger, Gordon Tait, Nicholas Mitsakakis, and Scott Beattie, Anesthesia and Pain Management, Toronto General Hospital, Toronto, Ontario, Canada. The effectiveness of ␤-blocker therapy for risk reduction during noncardiac surgery is contro-versial. Propensity score matching was used in 5,455 consecutive patients to match 202 pairs of patients undergoing noncardiac surgery who were receiving chronic preoperative ␤-blockers or who received these drugs acutely within 24 h of surgery. The composite outcome of major adverse cardiac events (relative risk 2.8) and myocardial infarction (relative risk 3.5) were significantly increased in patients (55% were at moderate to high risk for cardiac morbidity) receiving acute as compared with chronic ␤-blockers. The results suggest that timing and chronicity of ␤-blocker therapy might modulate the efficacy of risk reduction. [A781] "Perioperative Atenolol Is Associated with Reduced Mortality When Compared with Metoprolol" by Arthur W. Wallace, Selwyn Au, and Brian A. Cason, Anesthesiology and Perioperative Care, University of California San Francisco, San Francisco, California, and Anesthesiology Service, Veterans Affairs Medical Center, San Francisco, California. It has been suggested that the efficacy of ␤-blocker therapy for risk reduction in patients undergoing high risk surgery might be drug specific. Early and late mortality rates were compared in more than 5,000 patients undergoing either vascular or cardiac surgery and who received ␤-blocker therapy with either oral atenolol or metoprolol. Logistic regression analysis was used to correct for multiple confounding factors, and reduction in 30 day or 1 yr mortality rates (OR 0.5) favored atenolol as compared with metoprolol. The results suggest that the recent controversy concerning the efficacy of ␤-blockers in clinical trials may, in part, be related to the choice of drug. [A782] "Sepsis-induced Modulation of Ion Channels and the Role of Protein Nitrosylation in Atrial Myocytes" by Yuta Aoki, Noboru Hatakeyama, Hiroyuki Kinoshita, Naoyuki Matsuda, and Mitsuaki Yamazaki, Toyama University; Wakayama Medical University, and Nagoya University, Japan. The etiology of tachyarrhythmias during sepsis is unclear. Using a guinea pig model of sepsis (LPS), the role of protein nitrosylation via iNOS activation and subsequent changes in ion channels were investigated as potential responsible mechanisms. The expression of calcium channel subunits in atrial myocardium and calcium currents were decreased during sepsis, whereas potassium channel subunit expression was increased. These changes occurred concomitantly with increased atrial nitrotyrosine and were blocked by treatment with the nonspecific nitric oxide synthase inhibitor L-NAME. The results suggest that sepsis-induced increases in nitric oxide may produce changes in expression and regulation of ion channels in atrial myocytes, leading to changes in action potential shortening. Both hypertonic saline (7/5% NaCl) and mannitol (20%) are effective in reducing brain bulk during craniotomy. This randomized blinded trial compared these two treatments at equiosmolar doses in 160 subjects undergoing supratentorial craniotomy. The incidence of brain swelling and increased intracranial pressure were both significantly lower in the hypertonic saline group, which also had better operating conditions and less diuresis. The neural mechanisms governing general anesthesia induction and emergence are poorly understood. Neural network properties were measured using electroencephalography in 20 male volunteers during induction of and emergence from propofol anesthesia. Optimal network structure was globally disrupted at loss of consciousness with gradual recovery before emergence. In contrast, network connection strength did not change at loss of consciousness, but precipitously increased at return of consciousness. These distinct electrophysiological correlates support distinct neurobiological mechanisms underlying induction and emergence of anesthesia. [A783] "Returning from Oblivion: Brain Activity Correlated with Consciousness Following Anesthesia" by Jaakko W. Långsjö, Kimmo Kaskinoro, Sargo Aalto, Michael T. Alkire, and Harry Scheinin, Turku PET Centre, University of Turku, Finland, and University of California-Irvine. Previous neuroimaging studies have focused on changes associated with loss of consciousness following anesthesia rather than return of consciousness following anesthesia. Positron emission tomography (PET) scanning of cerebral blood flow as in index of brain activity was used to investigate the effects of propofol and dexmedetomidine in 20 male volunteers. Return of consciousness for each drug was associated with a significant increase in anterior cingulate cortex activity, a region proposed to play a critical role in consciousness. [A785] 3rd Annual ANESTHESIOLOGY/FAER Session: Debunking Myths of Transfusion Tuesday, October 19, 1:00 PM to 4:00 PM, Upper 28E, San Diego Convention Center, San Diego, California.
The safety and efficacy of perioperative blood product transfusion have become of prime importance with recent guidelines for coagulation testing and transfusion in the perioperative environment, and the controversial effect of "aged" red cell transfusion as an association and perhaps cause of adverse outcomes. The transformation of the perception of risks of blood transfusion from infectious to noninfectious etiologies is emphasized in the presentations and abstracts that will be presented at this year's ANESTHESIOLOGY/FAER session.
Several presentations illustrate the role and perhaps the etiology of increased risk of several cardiac and noncardiac outcomes after "aged" blood, first illustrated in depth, in cardiac patients, by Colleen Koch, M.D., of The Cleveland Clinic. Her research has spurred two large multicenter clinical trials and a renewed interest in the mechanism of transfusion-associated organ injury. Elliott Bennett-Guerrero, M.D., from the Duke Clinical Research Institute, Duke University, one of the leaders of these trials, will discuss the role of "new" versus "aged" blood on postoperative outcomes.
In an almost antithetical relationship, several moderate-size observational studies, predominantly originating from the U.S. military experience with trauma in recent wars, have found improved outcomes in patients treated with large doses of fresh frozen plasma. However, there are also studies in which no benefit of a high FFP:RBC on survival was found. John Holcomb, M.D., Director of the Center for Translational Injury Research at the University of Texas Health Science Center at Houston, will be presenting a summary and the implications of this work. Dr. Holcomb was head of the Army Institute of Surgical Research, Brooke Army Medical Center, and was lead author on many of these observational studies.
Donat R. Spahn, M.D., F.R.C.A., University Hospital, Zürich, will describe outcomes after transfusion: in extreme hemorrhage following trauma, where red cell transfusion can be life saving, and in most other situations in which red cell transfusion is consistently associated with major adverse clinical
